New to site?


Login

Lost password? (X)

Already have an account?


Signup

(X)
Farooq

Bayer announces publication of larotrectinib data in The New England Journal of Medicine

HomenewsBayer announces publication of larotrectinib data in The New England Journal of Medicine
26
Feb
Bayer announces publication of larotrectinib data in The New England Journal of Medicine
  • Author
    web
  • Comments
    0 Comments
  • Category

BayerBayer and Loxo Oncology, Inc., (NASDAQ: LOXO), a biopharmaceutical company from Stamford (Connecticut, US) announced the publication in The New England Journal of Medicine (NEJM) of larotrectinib data for the treatment of pediatric and adult patients whose tumors harbor Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusions.Original Article

Tags:

    Related Posts
    Leave A Comment

    Leave A Comment